About Teyro
Teyro is a Healthcare company based in Chennai (India) founded in 2016. It specializes in developing and manufacturing oncology pharmaceuticals. It operates on a B2B model. The company has 175 employees. Its Indian entity Teyro Labs Private Limited reported revenue of ₹15.00 Cr. Its focus areas include Pharmaceuticals, Oncology and Drug Development. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
Teyro operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, oncology, and drug development. Specializes in developing and manufacturing oncology pharmaceuticals. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Chennai, India
- Employees 175
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website teyro.com
- Social LinkedIn
- Legal Name Teyro Labs Private Limited
- Date of Incorporation 21 Feb, 2014
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹15.00 Cr
FY 2024 · +498% YoY
- Net Loss-₹23.11 Cr
FY 2024 · -154% margin
- EBITDA₹30.02 Cr
FY 2024 · 200% margin
- Employee Count175
Associated legal entities of Teyro
Teyro operates through Teyro Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Teyro Labs Private Limited CIN U24100TN2014PTC095150 | Active | 21 Feb 2014 | Chennai, Tamil Nadu | ₹15.0 Cr | 175 | 2 | View details |
Board of directors of Teyro Labs Private Limited (Teyro)
Teyro Labs Private Limited is the primary company behind Teyro. The board of Teyro Labs Private Limited currently have 2 directors; the longest-serving is Sundeep Anand Jegathrakshagan, appointed in 2014. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sundeep Anand Jegathrakshagan DIN 01728742 | Director | 01 Dec 2014 | 11 yrs 10 mo | Teyro Labs Private Limited |
| Jagathrakshakan Swamikannu DIN 01720227 | Director | 18 Aug 2023 | 3 yrs 2 mo | Teyro Labs Private Limited |
Financials of Teyro
Figures of Teyro Labs Private Limited, the primary company behind Teyro, for FY 2024. Revenue was ₹15.00 Cr (+498% year on year). Net loss was -₹23.11 Cr (-154% margin). EBITDA was ₹30.02 Cr (200% margin). Revenue has grown at a compounded annual rate of -6% over three years and +100% over five years.
- ₹15.00 CrRevenue · FY 2024 · +498% YoY
- -₹23.11 CrNet loss · -154% margin
- ₹30.02 CrEBITDA · 200% margin
- ₹36.65 CrPaid-up capital
- 175Employees (provident fund records)
- -6%Revenue CAGR, 3 years
- +100%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Teyro Labs Private Limited are on its company page.
Detailed financial statements for Teyro
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Teyro
Teyro has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of Teyro
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Teyro
The website of Teyro (teyro.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▲ 256.8% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Teyro
Complete news archive for Teyro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Teyro
Teyro was founded in 2016.
Teyro is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Teyro has 175 employees.
The primary company behind Teyro, Teyro Labs Private Limited, reported revenue of ₹15.00 Cr for FY 2024, up 498% year on year.
Teyro operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, oncology, and drug development. Specializes in developing and manufacturing oncology pharmaceuticals. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations. It continues to evolve, meeting industry challenges with strategic approaches.
Teyro's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Teyro operates through Teyro Labs Private Limited.
The legal entities of Teyro currently have 2 directors, including Jagathrakshakan Swamikannu, Sundeep Anand Jegathrakshagan.